Examen will share the latest research in male fertility at Fertility 2020, Edinburgh

By Sheena Lewis


There are many unanswered questions when it comes to male fertility research. Of couples seeking IVF treatment, the second most common reason is ‘unexplained’ fertility, accounting for 32% of cases1. There is clearly still significant research to be done and it is ever more important for fertility experts to come together and share the latest progress and research. Exact tests find out whether male sperm DNA could be the reason for infertility, miscarriage and even IVF and ICSI fertility treatments not being successful!

We’re dedicating everything we do to helping men become dads and we’ll be attending Fertility 2020 to share our latest male fertility study results. We’re on stand 48 and looking forward to meeting fellow fertility colleagues.

The theme for this year’s event is ‘Reproduction in a changing world’. The world is changing, thankfully more men are starting to talk and speak out about the problems they’re facing and what they and their partners are going through. The health of a man’s sperm will, without a doubt, impact whether or not he can get his partner pregnant and have a baby. High sperm DNA damage does increase the change of miscarriage as well as impacting the chances of fertility treatment success.

We’ll be at the show to discuss how our research is transforming the diagnosis and treatment of male infertility. According to HFEA, male infertility is the most common reason for IVF treatment1 and research has demonstrated that sperm DNA damage is associated with delayed natural conception and repeated miscarriage as well as the success of fertility treatments including IVF. Our latest study, conducted in collaboration with our friends, The Lister Fertility Clinic in London, demonstrated that the use of Examen’s COMET parameters (Exact tests) in sperm DNA analysis improves the diagnosis of unexplained infertility and the prediction of the outcome of both ICSI and IVF.

Our Exact portfolio of tests includes Exact IVFTM and Exact ICSITM. Exact is the go-to brand for sperm DNA fragmentation analysis, used by 80% of the UK’s leading fertility clinics. The Exact tests are robust biomarkers for male infertility, IVF and ICSI success, with the highest sensitivity, specificity and predictive power when compared to other sperm DNA tests.

If you share in our vision of helping men become dads, and your clinic fertility treatment success rates are important to you, then come and speak to us on stand 48 at Fertility 2020.

1 https://www.hfea.gov.uk/media/2563/hfea-fertility-trends-and-figures-2017-v2.pdf

Back to blog

Join our mailing list

Join our mailing list to receive Examen’s latest news, updates and information about upcoming events.

* indicates required
Is your interest:

For Healthcare Professionals


  • Unit 18A Block K
  • Weavers Court Business Park
  • Linfield Road
  • Belfast BT12 5GH
  • BSI Assurance Mark
  • BSI Assurance Mark, ISO 13485
  • Invest NI European Funding logo

© 2024 Examen Ltd. Exact® is a Registered Trade Mark.
Website Design by Bag of Bees Studio